Karyopharm’s selinexor

Who is an ideal candidate for karylief and what is the treatment protocol?

Karyleif appears to be a misspelling or variation of Karyopharm’s selinexor programs; available reporting describes selinexor (XPOVIO) studied chiefly in combination with ruxolitinib for treatment‑naï...